The compound binds selectively to melanocortin-1 receptors (MC1R) on melanocytes, triggering the enzymatic cascade that converts tyrosine to melanin
However, it should be used under medical supervision
Saxenda FDA Approval and Its Black Box Warning Saxenda received FDA approval on December 23, 2014, for weight loss management in adults with obesity or who are overweight (BMI of 27 kg/m or higher) with at least one weight-related medical condition
The right question is not only What does this peptide do? The better question is What is the actual diagnosis, what is the evidence for my situation, and what risks need to be considered before adding anything to the plan? BPC-157: What Patients Should Know BPC-157 is often discussed for gut and soft-tissue recovery
Melanotan peptide mimics the activity of -melanocyte stimulating hormone by binding to the melanocortin-1 receptor [MC1R] on melanocytes and activating the synthesis of eumelanin
We ensure there are no unnecessary synthetic fillers and that our sourcing is non-GMO and organic where possible